Mikio Yoshioka
Overview
Explore the profile of Mikio Yoshioka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishiguro N, Koseki N, Kaiho M, Ariga T, Kikuta H, Oba K, et al.
J Infect Chemother
. 2018 Mar;
24(6):449-457.
PMID: 29487035
The clinical effectiveness of four neuraminidase inhibitors (NAIs) (oseltamivir, zanamivir, laninamivir, and peramivir) for children aged 0 months to 18 years with influenza A and B were investigated in the...
2.
Ishiguro N, Koseki N, Kaiho M, Ariga T, Kikuta H, Togashi T, et al.
PLoS One
. 2017 Mar;
12(3):e0173635.
PMID: 28288170
Objective: To clarify therapeutic effects of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae (MRMP) pneumonia and against macrolide-sensitive Mycoplasma pneumoniae (MSMP) pneumonia in pediatric patients. Methods: A prospective,...
3.
Moritake H, Obara M, Saito Y, Kashimada A, Takagi M, Funakoshi-Tago M, et al.
Hum Cell
. 2016 Nov;
30(2):88-97.
PMID: 27885588
Major facilitator superfamily domain containing 2a (Mfsd2a) is a member of the major facilitator superfamily. Mfsd2a functions as a transporter for docosahexaenoic acid and also plays a role in the...
4.
Okura Y, Tsumagari S, Nawate M, Yoshioka M, Shikano T, Takahashi Y
J Pediatr
. 2016 Feb;
172:220.
PMID: 26858191
No abstract available.
5.
Koseki N, Teramoto S, Kaiho M, Gomi-Endo R, Yoshioka M, Takahashi Y, et al.
J Clin Microbiol
. 2012 Mar;
50(6):2118-21.
PMID: 22442328
Human bocaviruses (HBoV) 1, 2, 3, and 4 (HBoV1-4) were detected in 132 (15.5%), 5 (0.6%), 3 (0.4%), and 5 (0.6%) of 850 nasopharyngeal swab samples collected from children with...
6.
Teramoto S, Koseki N, Yoshioka M, Matsunami Y, Yanazume N, Nawate M, et al.
Pediatr Infect Dis J
. 2011 Sep;
30(10):918.
PMID: 21915023
No abstract available.
7.
Yoshioka M, Crum M, Sample J
J Virol
. 2007 Dec;
82(4):1679-87.
PMID: 18077719
Epstein-Barr virus (EBV) latent infection, and its associated oncogenic potential, is dependent on genome maintenance functions of EBV nuclear antigen 1 (EBNA-1), one of six EBNAs expressed from a common...
8.
Endo R, Yoshioka M, Ebihara T, Ishiguro N, Kikuta H, Kobayashi K
Med Hypotheses
. 2004 Aug;
63(4):582-7.
PMID: 15325000
Chronic active Epstein-Barr virus (EBV) infection has been recognized as clonal non-neoplastic lymphoproliferative diseases. However, some reports of cases with a multiphenotypic expansion of EBV-infected lymphocytes give rise to questions...
9.
Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K
J Med Virol
. 2003 May;
70(3):410-9.
PMID: 12767005
Expression of different panels of latent gene transcripts is controlled by usage of three distinct Epstein-Barr virus (EBV) nuclear antigen (EBNA) promoters (Wp, Cp, and Qp). EBV-associated hemophagocytic syndrome, which...
10.
Ebihara T, Endo R, Kikuta H, Ishiguro N, Yoshioka M, Ma X, et al.
J Med Virol
. 2003 Apr;
70(2):281-3.
PMID: 12696118
A new human pneumovirus, provisionally designated human metapneumovirus, was discovered by Dutch researchers. We examined 142 serum samples from the general population aged from 1 month to 35 years in...